Лечение L-депренилом гипофиз-зависимого гиперкортицизма: литература
Bruyette DS: Alternatives in the treatment of hyperadrenocorticism in dogs and cats. In: Kirk RW, ed: Kirk's Current Veterinary Therapy XII. Philadelphia: WB Saunders, 1995, p 421. This chapter renews a number of treatment options for managing hyperadrenocorticism in dogs and cats in addition to o,p '-DDD and ketoconazole.
Bruyette DS, Ruehl WW, Entriken TL: Spontaneous canine pituitary dependent hyperadrenocorticism: A potential model for neurodegener-ative disorders. Prog Brain Res 106:207, 1995. This article presents the results of a large, prospective clinical trial of L-deprenyl in dogs with pituitary-dependent hyperadrenocorticism.
Bruyette DS, Ruehl WW, Entriken TL, et al: Management of canine pituitary dependent hyperadrenocorticism with L-deprenyl (Anipryl). Vet Clin North Am Small Anim Pract, 27:273, 1997. This chapter provides an overview on the rationale for L-deprenyl in the management of canine pituitary-dependent hyperadrenocorticism and summarizes the results of the various clinical trials.
Bruyette DS, Ruehl WW, Smidberg TL: Therapy of canine pituitary dependent hyperadrenocorticism with L-deprenyl. J Vet Intern Med 7:114, 1993 [abstract]. This abstract describes the initial pilot study of L- deprenyl in the treatment of canine pituitary-dependent hyperadrenocorticism.
Gerlach M, Riederer P, Youdim MH: The mode of action of MAO-B inhibitors. In: Szelenyi I, ed: Inhibitors of Monoamine Oxidase B: Pharmacology and Clinical Use in Neurodegenerative Disorders. Birk- hauser, Basel, 1993, p 183. This chapter provides an excellent overview of the mechanisms of action of L-deprenyl and its use in a number of neurodegenerative disorders.
Peterson ME, Palkovits M, Chiueh CC, et al: Biogenic amine and cortico-tropin-releasing factor concentrations in hypothalamic paraventricular nucleus and biogenic amine levels in the median eminence of normal dogs, chronic dexamethasone treated dogs, and dogs with naturally-occurring pituitary-dependent hyperadrenocorticism (canine Cushing's disease). J Neuroendocrinol 1:169, 1989. This paper documents hypothalamic dopamine depletion in dogs with pituitary-dependent hyperadrenocorticism.
